PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS

Published

Conference Paper

ACTR-28

Full Text

Duke Authors

Cited Authors

  • Peters, K; Kirkpatrick, J; Batinic-Haberle, I; Affronti, M; Woodring, S; Iden, D; Panta, S; Lipp, E; Healy, P; Herndon, J; Spasojevic, I; Penchev, S; Gad, S; Siberstein, D; Johnson, M; Randazzo, D; Desjardins, A; Friedman, H; Ashley, D; Crapo, J

Published Date

  • November 5, 2018

Published In

Volume / Issue

  • 20 / suppl. 6; abstr QOLP-13

Start / End Page

  • 1vi7 - vi17

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

International Standard Serial Number (ISSN)

  • 1522-8517

Digital Object Identifier (DOI)

  • 10.1093/neuonc/noy148.061

Conference Name

  • 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference

Conference Location

  • New Orleans, LA

Conference Start Date

  • November 14, 2018

Conference End Date

  • November 18, 2018